US Stock MarketDetailed Quotes

Esperion Therapeutics (ESPR)

Watchlist
  • 2.040
  • -0.010-0.49%
Close Apr 17 16:00 ET
  • 2.050
  • +0.010+0.49%
Post 19:59 ET
525.11MMarket Cap-18.55P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Esperion Therapeutics (ESPR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
21.31%403.14M
143.73%168.45M
69.10%87.31M
11.58%82.39M
-52.81%65M
185.66%332.31M
114.30%69.11M
52.00%51.63M
186.33%73.83M
466.14%137.74M
Operating revenue
21.31%403.14M
143.73%168.45M
69.10%87.31M
11.58%82.39M
-52.81%65M
185.66%332.31M
114.30%69.11M
52.00%51.63M
186.33%73.83M
466.14%137.74M
Cost of revenue
88.37%129.22M
8.67%27.85M
138.86%41.29M
82.86%28.54M
213.03%31.54M
58.55%68.6M
123.81%25.63M
29.22%17.29M
130.02%15.61M
-13.53%10.08M
Gross profit
3.87%273.91M
223.33%140.59M
33.99%46.02M
-7.53%53.84M
-73.79%33.46M
260.92%263.71M
109.07%43.48M
66.79%34.35M
206.45%58.23M
907.02%127.66M
Operating expense
2.07%213.64M
15.57%55.36M
11.13%55.98M
-15.99%46.75M
0.29%55.55M
-8.45%209.31M
-24.16%47.9M
4.67%50.37M
-0.73%55.65M
-9.61%55.39M
Selling and administrative expenses
1.66%165.79M
12.21%41.43M
4.69%41.85M
-10.58%39.51M
2.40%43M
14.42%163.07M
-18.71%36.93M
20.26%39.98M
30.11%44.19M
40.42%41.99M
Research and development costs
3.49%47.85M
26.87%13.93M
35.91%14.13M
-36.85%7.24M
-6.31%12.56M
-46.30%46.24M
-38.13%10.98M
-30.15%10.4M
-48.14%11.46M
-57.29%13.4M
Operating profit
10.79%60.27M
2,028.35%85.23M
37.86%-9.96M
175.11%7.1M
-130.57%-22.1M
134.97%54.4M
89.57%-4.42M
41.79%-16.03M
106.96%2.58M
248.69%72.27M
Net non-operating interest income expense
-42.79%-84.6M
-37.84%-22.64M
-46.21%-22.05M
-49.28%-20.49M
-38.56%-19.43M
-0.47%-59.25M
-9.07%-16.42M
-0.58%-15.08M
5.60%-13.72M
2.52%-14.02M
Non-operating interest expense
42.79%84.6M
37.84%22.64M
46.21%22.05M
49.28%20.49M
38.56%19.43M
0.47%59.25M
9.07%16.42M
0.58%15.08M
-5.60%13.72M
-2.52%14.02M
Other net income (expense)
107.44%3.49M
325.84%1.08M
-57.26%677K
101.31%666K
-61.40%1.07M
-986.34%-46.9M
-144.07%-476K
23.94%1.58M
-3,159.10%-50.78M
118.15%2.78M
Special income (charges)
--0
--0
--0
--0
----
---54.92M
---1.68M
--0
---53.24M
----
-Less:Other special charges
----
----
----
----
----
--54.92M
--1.68M
----
--53.24M
----
Other non- operating income (expenses)
-56.49%3.49M
-10.94%1.08M
-57.26%677K
-72.86%666K
-61.40%1.07M
51.62%8.02M
11.76%1.21M
23.94%1.58M
47.83%2.45M
118.15%2.78M
Income before tax
59.72%-20.84M
398.68%63.67M
-6.13%-31.33M
79.45%-12.73M
-166.30%-40.46M
75.27%-51.75M
62.16%-21.32M
28.43%-29.52M
-24.01%-61.93M
198.87%61.02M
Income tax
1.84M
0
Net income
56.17%-22.68M
390.04%61.83M
-6.13%-31.33M
79.45%-12.73M
-166.30%-40.46M
75.27%-51.75M
62.16%-21.32M
28.43%-29.52M
-24.01%-61.93M
198.87%61.02M
Net income continuous Operations
56.17%-22.68M
390.04%61.83M
-6.13%-31.33M
79.45%-12.73M
-166.30%-40.46M
75.27%-51.75M
62.16%-21.32M
28.43%-29.52M
-24.01%-61.93M
198.87%61.02M
Minority interest income
Net income attributable to the parent company
56.17%-22.68M
390.04%61.83M
-6.13%-31.33M
79.45%-12.73M
-166.30%-40.46M
75.27%-51.75M
62.16%-21.32M
28.43%-29.52M
-24.01%-61.93M
198.87%61.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
56.17%-22.68M
390.04%61.83M
-6.13%-31.33M
79.45%-12.73M
-166.30%-40.46M
75.27%-51.75M
62.16%-21.32M
28.43%-29.52M
-24.01%-61.93M
198.87%61.02M
Basic earnings per share
60.71%-0.11
336.36%0.26
-6.67%-0.16
81.82%-0.06
-158.33%-0.21
86.21%-0.28
78.00%-0.11
59.46%-0.15
28.26%-0.33
145.57%0.36
Diluted earnings per share
60.71%-0.11
300.00%0.22
-6.67%-0.16
81.82%-0.06
-161.76%-0.21
86.21%-0.28
78.00%-0.11
59.46%-0.15
28.26%-0.33
143.04%0.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 21.31%403.14M143.73%168.45M69.10%87.31M11.58%82.39M-52.81%65M185.66%332.31M114.30%69.11M52.00%51.63M186.33%73.83M466.14%137.74M
Operating revenue 21.31%403.14M143.73%168.45M69.10%87.31M11.58%82.39M-52.81%65M185.66%332.31M114.30%69.11M52.00%51.63M186.33%73.83M466.14%137.74M
Cost of revenue 88.37%129.22M8.67%27.85M138.86%41.29M82.86%28.54M213.03%31.54M58.55%68.6M123.81%25.63M29.22%17.29M130.02%15.61M-13.53%10.08M
Gross profit 3.87%273.91M223.33%140.59M33.99%46.02M-7.53%53.84M-73.79%33.46M260.92%263.71M109.07%43.48M66.79%34.35M206.45%58.23M907.02%127.66M
Operating expense 2.07%213.64M15.57%55.36M11.13%55.98M-15.99%46.75M0.29%55.55M-8.45%209.31M-24.16%47.9M4.67%50.37M-0.73%55.65M-9.61%55.39M
Selling and administrative expenses 1.66%165.79M12.21%41.43M4.69%41.85M-10.58%39.51M2.40%43M14.42%163.07M-18.71%36.93M20.26%39.98M30.11%44.19M40.42%41.99M
Research and development costs 3.49%47.85M26.87%13.93M35.91%14.13M-36.85%7.24M-6.31%12.56M-46.30%46.24M-38.13%10.98M-30.15%10.4M-48.14%11.46M-57.29%13.4M
Operating profit 10.79%60.27M2,028.35%85.23M37.86%-9.96M175.11%7.1M-130.57%-22.1M134.97%54.4M89.57%-4.42M41.79%-16.03M106.96%2.58M248.69%72.27M
Net non-operating interest income expense -42.79%-84.6M-37.84%-22.64M-46.21%-22.05M-49.28%-20.49M-38.56%-19.43M-0.47%-59.25M-9.07%-16.42M-0.58%-15.08M5.60%-13.72M2.52%-14.02M
Non-operating interest expense 42.79%84.6M37.84%22.64M46.21%22.05M49.28%20.49M38.56%19.43M0.47%59.25M9.07%16.42M0.58%15.08M-5.60%13.72M-2.52%14.02M
Other net income (expense) 107.44%3.49M325.84%1.08M-57.26%677K101.31%666K-61.40%1.07M-986.34%-46.9M-144.07%-476K23.94%1.58M-3,159.10%-50.78M118.15%2.78M
Special income (charges) --0--0--0--0-------54.92M---1.68M--0---53.24M----
-Less:Other special charges ----------------------54.92M--1.68M------53.24M----
Other non- operating income (expenses) -56.49%3.49M-10.94%1.08M-57.26%677K-72.86%666K-61.40%1.07M51.62%8.02M11.76%1.21M23.94%1.58M47.83%2.45M118.15%2.78M
Income before tax 59.72%-20.84M398.68%63.67M-6.13%-31.33M79.45%-12.73M-166.30%-40.46M75.27%-51.75M62.16%-21.32M28.43%-29.52M-24.01%-61.93M198.87%61.02M
Income tax 1.84M0
Net income 56.17%-22.68M390.04%61.83M-6.13%-31.33M79.45%-12.73M-166.30%-40.46M75.27%-51.75M62.16%-21.32M28.43%-29.52M-24.01%-61.93M198.87%61.02M
Net income continuous Operations 56.17%-22.68M390.04%61.83M-6.13%-31.33M79.45%-12.73M-166.30%-40.46M75.27%-51.75M62.16%-21.32M28.43%-29.52M-24.01%-61.93M198.87%61.02M
Minority interest income
Net income attributable to the parent company 56.17%-22.68M390.04%61.83M-6.13%-31.33M79.45%-12.73M-166.30%-40.46M75.27%-51.75M62.16%-21.32M28.43%-29.52M-24.01%-61.93M198.87%61.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 56.17%-22.68M390.04%61.83M-6.13%-31.33M79.45%-12.73M-166.30%-40.46M75.27%-51.75M62.16%-21.32M28.43%-29.52M-24.01%-61.93M198.87%61.02M
Basic earnings per share 60.71%-0.11336.36%0.26-6.67%-0.1681.82%-0.06-158.33%-0.2186.21%-0.2878.00%-0.1159.46%-0.1528.26%-0.33145.57%0.36
Diluted earnings per share 60.71%-0.11300.00%0.22-6.67%-0.1681.82%-0.06-161.76%-0.2186.21%-0.2878.00%-0.1159.46%-0.1528.26%-0.33143.04%0.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -